Emergent Biosolutions EBS Market capitalization

Market capitalization at other companies

Thermo Fisher ScientificTMO

$190.65B+24.9%

Regeneron PharmaceuticalsREGN

$65.37B+15.9%

SIGA TechnologiesSIGA

$261.08M-42.9%

AMP

Amphastar PharmaceuticalsAMPH

$889.8M-23.2%

Amneal Pharmaceuticals, Inc.AMRX

$5.53B+117%

Lifecore Biomedical, Inc.LFCR

$164.67M-42.2%

FAQ

What is Emergent Biosolutions's market capitalization?

Emergent Biosolutions (EBS) reported market capitalization of $432.38M in Q2 2026.

How has Emergent Biosolutions's market capitalization changed year-over-year?

Emergent Biosolutions's market capitalization increased by 17.7% year-over-year, from $367.46M to $432.38M.

What is the long-term trend for Emergent Biosolutions's market capitalization?

Over 5 years (2020 to 2025), Emergent Biosolutions's market capitalization has grown at a -33.0% compound annual growth rate (CAGR), from $4.82B to $649.15M.

What does market capitalization mean?

The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.